23M-17813-60781
2 vaccinations
9 coded responses
19 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 951 / CA
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-08
Dose 1 — Pfizer-BioNTech
-
2021-01-12
Registered in v-safe
-
2021-01-12
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · None · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-12
Report sent to call center — days 1–6 daily, dose 1Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Survey response — days 1–6 daily, dose 1MedDRA: Skin exfoliation — Feeling: GoodFree text: Flaking starting from my nose, arms the next day, legs the next day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-18
- 2021-01-23
-
2021-01-29
Dose 2 — Pfizer-BioNTech
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-31
Survey response — days 1–6 daily, dose 2MedDRA: Dyspepsia — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, Abdominal painFree text: HeartburnMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-01
Survey response — days 1–6 daily, dose 2MedDRA: Dry skin — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Skin dryness, some dry patches and peeling at the face.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-02
-
2021-02-03
Survey response — days 1–6 daily, dose 2MedDRA: Night sweats — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Night sweatsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-04
- 2021-02-05
- 2021-02-12
-
2021-02-19
Survey response — day 21, dose 2MedDRA: Abdominal pain, Dyspepsia, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Heartburn, abdominal pain, headaches, fatigueMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-03-06
-
2021-03-15
Survey response — day 42, dose 2MedDRA: Abdominal discomfort, Decreased appetite — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Extreme Fatigue. Gut and stomach irritation after eating. Loss of appetite.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-03
Survey response — 3 months, dose 2MedDRA: Decreased appetite, Odynophagia, Oropharyngeal pain — Feeling: FairFree text: Sore throat, pain with swallowing, decreased appetiteMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-30
Survey response — 6 months, dose 2MedDRA: Abdominal distension, Abnormal menstrual clots, Anaemia — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Anemia, one menstrual period with excessive clots, excess bloating in intenstines.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-07-30
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-05
-
2022-01-29
Survey response — 12 months, dose 2MedDRA: Cough, Lethargy, Oropharyngeal pain, Respiratory tract congestion, Temperature regulation disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Congestion, lethargy, difficulty regulating body temperature, sore throat and cough. From roughly 1/5-1/22MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-08 | Pfizer-BioNTech | |
| 2 | 2021-01-29 | Pfizer-BioNTech |
Call center
2 call center cases
1 unsuccessful · 1 priority 2/3 (triaged and no follow up)
Free text
Release 2 — days 1–6 daily, dose 1
Systemic reaction (other): Flaking starting from my nose, arms the next day, legs the next day.
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Heartburn
Systemic reaction (other): Skin dryness, some dry patches and peeling at the face.
Systemic reaction (other): Night sweats
Release 4 — day 21, dose 2
Symptoms: Heartburn, abdominal pain, headaches, fatigue
Release 5 — day 42, dose 2
Symptoms: Extreme Fatigue. Gut and stomach irritation after eating. Loss of appetite.
Release 8 — 3 months, dose 2
Symptoms: Sore throat, pain with swallowing, decreased appetite
Release 9 — 6 months, dose 2
Symptoms: Anemia, one menstrual period with excessive clots, excess bloating in intenstines.
Release 11 — 12 months, dose 2
Symptoms: Congestion, lethargy, difficulty regulating body temperature, sore throat and cough. From roughly 1/5-1/22
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal discomfort | ✓ | ✓ | ✓ |
| SD | Abdominal distension | ✓ | · | ✓ |
| SD | Abdominal pain | ✓ | ✓ | ✓ |
| SD | Abnormal menstrual clots | ✓ | · | ✓ |
| SD | Anaemia | ✓ | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Decreased appetite | ✓ | ✓ | ✓ |
| SD | Dyspepsia | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Odynophagia | ✓ | ✓ | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Temperature regulation disorder | · | · | ✓ |
| SRO | Dry skin | ✓ | ✓ | ✓ |
| SRO | Dyspepsia | ✓ | ✓ | ✓ |
| SRO | Night sweats | ✓ | ✓ | ✓ |
| SRO | Skin exfoliation | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release